Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Training for Adolescents With Special Healthcare Needs

Published: Mon, 18 Jun 2018 12:00:00 EDT
Could this new provider training program help adolescents and young adults with special healthcare needs successfully transition from pediatric to adult care?
Pediatric Nursing

ADT and Prolongation of QTc Interval in Prostate Cancer

Published: Mon, 18 Jun 2018 12:00:00 EDT
Could changes in QTc duration during androgen deprivation therapy for prostate cancer help explain the increased risk for cardiovascular events in these patients?
Journal of the Endocrine Society

Reducing Unplanned Acute Care for Patients With Cancer

Published: Mon, 18 Jun 2018 12:00:00 EDT
Early use of palliative care and identification of patients at risk are strategies that may reduce acute care in patients with cancer.
Journal of Oncology Practice

Patient Violence: It's Not All in a Day's Work

Published: Mon, 18 Jun 2018 12:00:00 EDT
What strategies may help nurses manage violent behaviors in patients and minimize the risk of being victimized?
American Nurse Today
Displaying results 5-8 (of 20)
 1 - 2 - 3 - 4 - 5 


Selecta unveils more data on its gout treatment, commits to phase 3 study launch this year

Published: Thu, 14 Jun 2018 18:14:06 +0000
Selecta Biosciences presented more new data from an ongoing phase 2 trial of its enzyme treatment for gout, which the company said outperformed standard treatment and has convinced it to soldier on to a phase 3 clinical program before the end of the year.

All-in-one CAR-T packages therapy and safety in one molecule

Published: Thu, 14 Jun 2018 16:55:04 +0000
French biotech Cellectis has devised a form of CAR-T that contains its therapeutic effects with a safeguard in a single molecule. The company believes the invention will pave the way to off-the-shelf CAR-T treatments.

Argenx boosts pipeline with new version of lead drug

Published: Thu, 14 Jun 2018 13:56:19 +0000
Argenx has the first data on a new subcutaneous formulation of its rare autoimmune disease drug efgartigimod that could make it a much more patient-friendly prospect.

Harnessing ‘rogue’ stem cells to grow healthy fat could help treat metabolic disorders

Published: Thu, 14 Jun 2018 13:30:49 +0000
Scientists at American University have discovered a potential method for treating obesity by controlling the process by which stem cells differentiate into fat cells. It revolves around dormant cells that have the potential to turn into several tissue types, including healthy fat.
Displaying results 5-8 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy